GenVec (GNVC) Receives Third-Year Funding from NIAID for HIV Vaccine Contract
Tweet Send to a Friend
GenVec (Nasdaq: GNVC) announced that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
